Abstract
The cytotoxic activity of two bioactive molecules obtained from Croton species, caracasine acid (monomer) and micansinoic acid (dimer) belonging to the group of the seco-ent-kaurenes was evaluated against the prostate cancer cell line PC3 and human dermis fibroblasts (control cells). In addition, the combination of the monomer and dimer was realized with the antitumoral drugs taxol and adriamycin. The PC3 and normal cells were growth-inhibited in a dosedependent manner after exposure to both natural products. These two seco-ent-kaurenes exhibited practically the similar cytotoxic activity against human tumor cells but not to normal cells. The monomer and the dimer in combination with adriamycin and taxol respectively showed a synergistic effect on tumor cells, resulting that the combination of adriamycin with the monomer or dimer was more effective than with the taxol. Moreover, the combination of monomer and dimers showed a strong antagonistic effect.
Keywords: Prostate cancer, Croton micans, Seco-ent-kaurene, Monomer, Dimer, Combination index, Synergism, Tumor therapy.
Letters in Drug Design & Discovery
Title:Cytotoxic Effects of the Monomer and Dimer of 3, 4-seco-ent-kaurene from Croton Micans and their Interaction with Antitumoral Drugs on Cellular Line of Human Prostate Cancer
Volume: 10 Issue: 8
Author(s): Jennire Vivas, Felipe Sojo, Katiuska Chavez, Alírica I. Suarez and Francisco Arvelo
Affiliation:
Keywords: Prostate cancer, Croton micans, Seco-ent-kaurene, Monomer, Dimer, Combination index, Synergism, Tumor therapy.
Abstract: The cytotoxic activity of two bioactive molecules obtained from Croton species, caracasine acid (monomer) and micansinoic acid (dimer) belonging to the group of the seco-ent-kaurenes was evaluated against the prostate cancer cell line PC3 and human dermis fibroblasts (control cells). In addition, the combination of the monomer and dimer was realized with the antitumoral drugs taxol and adriamycin. The PC3 and normal cells were growth-inhibited in a dosedependent manner after exposure to both natural products. These two seco-ent-kaurenes exhibited practically the similar cytotoxic activity against human tumor cells but not to normal cells. The monomer and the dimer in combination with adriamycin and taxol respectively showed a synergistic effect on tumor cells, resulting that the combination of adriamycin with the monomer or dimer was more effective than with the taxol. Moreover, the combination of monomer and dimers showed a strong antagonistic effect.
Export Options
About this article
Cite this article as:
Vivas Jennire, Sojo Felipe, Chavez Katiuska, Suarez I. Alírica and Arvelo Francisco, Cytotoxic Effects of the Monomer and Dimer of 3, 4-seco-ent-kaurene from Croton Micans and their Interaction with Antitumoral Drugs on Cellular Line of Human Prostate Cancer, Letters in Drug Design & Discovery 2013; 10 (8) . https://dx.doi.org/10.2174/15701808113109990021
DOI https://dx.doi.org/10.2174/15701808113109990021 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design Molecular Docking Analysis of Flavonoid Compounds with Matrix Metalloproteinase- 8 for the Identification of Potential Effective Inhibitors
Letters in Drug Design & Discovery The Effects of Kisspeptin in Human Reproductive Function – Therapeutic Implications
Current Drug Targets Glucose-6-Phosphate Dehydrogenase Deficiency: Disadvantages and Possible Benefits
Cardiovascular & Hematological Disorders-Drug Targets Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid
Current Pharmaceutical Design Metabolite Quantification in Tumours by Magnetic Resonance Spectroscopy: Objectives, Results and Perspectives
Current Medical Imaging Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy Two Handy Geometric Prediction Methods of Cancer Growth
Current Medical Imaging Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities
Current Topics in Medicinal Chemistry Molecular Surgery with Auger Electron-Emitting Radiopharmaceuticals
Current Radiopharmaceuticals Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Topics in Medicinal Chemistry Carotenoids of Microalgae Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase IIα As Novel Anticancer Agents
Current Medicinal Chemistry Cardiovascular Tests: Use & Limits of Biochemical Markers - Therapeutic Measurements of ADMA Involved in Cardiovascular Disorders
Current Pharmaceutical Design Estrogen Receptors: Mechanism of Action and Relevance to Schizophrenia
Current Psychiatry Reviews NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design Synthesis and Clinical Development of Palbociclib: An Overview
Medicinal Chemistry